[
  {
    "My Clinical Question (condition: other)": "***"
  },
  {
    "My most current assessment of this problem can be found in the note dated": "{Today/***}"
  },
  {
    "In your clinical question, or current note, please include information on": {
      "Assessments": {
        "Required": [],
        "Optional": [
          {
            "Cultures, pathology, serology, imaging, and other results, if applicable": "***"
          },
          {
            "Exposures and/or risk factors, if applicable": "***"
          },
          {
            "Treatments, if applicable": "***"
          }
        ]
      },
      "Diagnostics": [
        {
          "CBC, if applicable": "***"
        }
      ],
      "Clinical Pearls": [
        {
          "Detailed information about PrEP for clinicians can be found at https://www.cdc.gov/hiv/clinicians/prevention/prep.html for details regarding PrEP": "***"
        },
        {
          "Patients on PrEP should have HIV testing every 3 months to screen for breakthrough cases of HIV": "***"
        },
        {
          "Patients on PrEP with FTC-TDF (Truvada) should have a BMP/Cystatin-C every 3 months to monitor renal function": "***"
        },
        {
          "Consider STI testing for syphilis, gonorrhea, and chlamydia every 3 months for patients who state that they are at risk. Remember that gonorrhea and chlamydia must be tested by site": "***"
        }
      ]
    }
  }
]
